Suppr超能文献

硝苯地平、地尔硫䓬及其联合用药治疗慢性稳定性心绞痛的疗效

[Effectiveness of nifedipine, diltiazem and their combination in the treatment of chronic stable angina pectoris].

作者信息

Meluzín J, Lupínek Z, Koukalová H

机构信息

I. interní klinika fakultní nemocnice s poliklinikou KUNZ, Brno.

出版信息

Cas Lek Cesk. 1990 Aug 3;129(31):974-8.

PMID:2208231
Abstract

In a double blind crossed ten-week study with a randomized beginning the authors compared in 25 patients with chronic stable angina pectoris (II-III according to NYHA classification) and with normal blood pressure the effect of placebo, nifedipine, diltiazem and in 16 of the patients (who completed treatment with the combined drugs) also a combination of nifedipine and diltiazem. Nifedipine, 60 mg per day, and diltiazem, 270 mg per day, improved significantly the total amount of performed work as compared with placebo, they delayed significantly the onset of stenocardias and reduced the ST depression in lead V5 during ergometry, they reduced significantly the rate of stenocardias per day as well as the nitroglycerin consumption. Diltiazem, as compared with nifedipine, increased significantly the total volume of performed work and delayed the development of stenocardias during ergometry, the symptomatic improvement of the patients being similar. A combination of 30 mg nifedipine per day with 180 mg diltiazem per day did not lead to improvement, as compared with a higher dose of diltiazem alone, as compared with a higher dose of diltiazem alone. A combination of 60 mg nifedipine per day with 270 mg diltiazem per day did not improve the exercise tolerance, as compared with diltiazem alone, however, it reduced significantly the rate of stenocardias. However, the combination of the latter amounts was tolerated without side-effects only by 13% of the patients (2 of 15 patients), 53% (8 of 15 patients) terminated treatment prematurely because of several side-effects.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在一项为期十周的双盲交叉研究中,研究始于随机分组,作者比较了25例慢性稳定型心绞痛患者(根据纽约心脏协会分类为II - III级)且血压正常的情况下,安慰剂、硝苯地平、地尔硫䓬的效果,其中16例患者(完成联合用药治疗)还使用了硝苯地平和地尔硫䓬的组合。与安慰剂相比,每天60毫克的硝苯地平和每天270毫克的地尔硫䓬显著改善了总工作量,显著延迟了心绞痛发作,并降低了运动试验期间V5导联的ST段压低,显著降低了每日心绞痛发生率以及硝酸甘油消耗量。与硝苯地平相比,地尔硫䓬显著增加了总工作量,并在运动试验期间延迟了心绞痛的发展,患者的症状改善相似。与单独使用较高剂量的地尔硫䓬相比,每天30毫克硝苯地平与每天180毫克地尔硫䓬的组合并未带来改善。与单独使用地尔硫䓬相比,每天60毫克硝苯地平与每天270毫克地尔硫䓬的组合并未改善运动耐量,然而,它显著降低了心绞痛发生率。然而,只有13%的患者(15例中的2例)能够耐受后一种剂量组合且无副作用,53%(15例中的8例)因多种副作用提前终止治疗。(摘要截取自250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验